drugset / Trial / NCT00790751

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

NCT00790751

Phase 3 Completed 646 enrolled VIVUS LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.

Timeline

Start
2008-11
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 50 mg Oral
Subject Avanafil Small molecule 100 mg Oral
Subject Avanafil Small molecule 200 mg Oral

Indications